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<3 square mile area around the city of Makkah. Hajjis can
experience physical and emotional stress with limited
healthcare access. Cardiovascular events were the main
cause of death during Hajj for the last decade; therefore
the Strategic Cardiac Hajj Interventional Pro-
gram(SCHIP) was launched in 2009 to provide improved
cardiac outcomes.
Aim: To assess the impact of SCHIP on cardiac mor-
tality during Hajj.
Methods: A team of Cardiologists, specialists, nurses
with access to three cardiac catherization laboratories
provided 24-h-a-day support to 13 local hospitals
throughout the Hajj period. Cardiac and all causes mor-
tality adjusting for the potential other covariates were
statistically analyzed using time series data before and
after intervention.
Results: Cardiac death rates during 2006, 2007 and
2008 were 51.7%, 50.6% and 53.2%. After SCHIP introduc-
tion rates in 2009, 2010 and 2011 were 27%, 32.5% and
21.5%. The in-hospital mortality for ACS were 4.7%,
4.6% and 3.0%. The number of cardiac procedure per-
formed in 2 weeks during Hajj 2009, 2010, and 2011 were
183, 288 and 550. The majority of the procedure in the last
3 years were coronary catherization 90.1%, 80.9% and
86.7% . The rates of open heart surgery were 7%, 5.2%
and 4.5% .
Conclusion: After introduction of SCHIP, cardiac
and in-hospital mortality substantially reduced. Future
introduction of mobile cardiac catherization laboratories
may further reduce cardiac mortality.
http://dx.doi:10.1016/j.jsha.2012.06.203
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Objectives: To compare 201Tl (201-Thallium) single
photon emission CT (SPECT) and cardiac MRI (cMRI)
for identifying regions of reversible myocardial
dysfunction.
Methods: We conducted an experimental study to
compare both modalities by finding the area under
ROC curve and coefficient of variability in 42 cases (714
cardiac segments) after a pilot study on 16 cases. We also
compared the two modalities by an ingenious method
validated in pilot study with common physiological vari-
able, regional wall motion abnormality vs viability
assessed independently by both the modalities.
Results: The correlation coefficient in the detection
of perfusion defects by both the diagnosing modalities
was 0.89 and diagnostic region of operating characteris-
tics was 0.97. The sensitivity was 0.96 by 201Tl-SPECT
and 0.98 by cMRI, whereas the specificity 0.84 by 201Tl-
SPECT and 0.85 by cMRI. The positive and negative pre-
dictive value was 0.95 and 0.85 by 201Tl-SPECT, 0.97 and
0.90 by cMRI, respectively. The accuracy of evaluating the
viability was 93.15 and 95.69 by the 201Tl-SPECT and
cMRI respectively with a ‘p’ value of <0.0001.
Conclusion: The study shows a good sensitivity and
correlation of both 201Tl-SPECT and cMRI in diagnosing
the extent and number of perfusion defects in the myo-
cardium. cMRI is more accurate than 201Tl-SPECT in
not only diagnosing myocardial infarcts but also shows
its exact location and extent; this is likely to be of use in
patients with equivocal 201Tl-SPECT studies. The results
were concordant with the other international studies.
This is one of the largest study ever carried on compari-
son of these two modalities.
http://dx.doi:10.1016/j.jsha.2012.06.204
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Background and study aims: Cardiovascular dis-
eases (CVD) are the leading cause of death worldwide.
Among all CVDs, coronary heart disease (CHD) is the
most common. While data for CHD and its risk factors
are available for different regions and countries, the
Middle East lacks such reliable data. The CEPHEUS-
MIDDLE EAST study (ClinicalTrials.gov ID: NCT
01031277) was performed to gain a unique perspective
on the potential undertreatment of hypercholesterolemia
in this area.
Patients and methods: This multi-centric, non-
interventional study recruited a total of 5457 consecutive
patients by 177 specialists and general practitioners in
Saudi Arabia, United Arab Emirates, Kuwait, Qatar, Bah-
rain and Oman between 22 November 2009 and 07 July
2010. Data collection (Investigator and Patient Question-
naires, Patient Record Form and a fasting blood sample)
occurred at a single visit.
Results: Subjects were 58.16% male (n = 3060) with a
mean age of 55.56 years. The reasons for being pharma-
cologically treated were primary (71.54%; n = 3773), sec-
ondary prevention (27.27%; n = 1438) and familial
hypercholesterolemia (1.19%; n = 63). The most frequent
treatments were with statins (94.43%; n = 5260) or fibrates
(3.12%; n = 174). According to the Patient Questionnaire,
only 43.91% (2304) of patients had been informed about
their cholesterol levels, even though, according to the
Investigator Questionnaire, physicians set individual tar-
get cholesterol levels for 70.00% of their patients. The
majority of physicians (87.57% ; n = 155), reported to use
guidelines to establish target cholesterol levels, with the
NCEP ATP III being the most used frequently used
(46.53%; n = 67).
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